RB1 c.536G>C ;(p.S179T)

Variant ID: 13-48921996-G-C

NM_000321.2(RB1):c.536G>C;(p.S179T)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021-10-19

Variant appearance in text: RB1: S179T
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 9
View BVdb publication page



Proteogenomics Reveals Perturbed Signaling Networks in Malignant Melanoma Cells Resistant to BRAF Inhibition.

Molecular & Cellular Proteomics : Mcp
Schmitt, Marisa M; Sinnberg, Tobias T; Bratl, Katrin K; Zittlau, Katharina K; Garbe, Claus C; Macek, Boris B; Nalpas, Nicolas C NC
Publication Date: 2021

Variant appearance in text: RB1: S179T
PubMed Link: 34673281
Variant Present in the following documents:
  • mmc2.xlsx, sheet 9
View BVdb publication page



Megakaryocytes in Myeloproliferative Neoplasms Have Unique Somatic Mutations.

The American Journal Of Pathology
Guo, Belinda B BB; Allcock, Richard J RJ; Mirzai, Bob B; Malherbe, Jacques A JA; Choudry, Fizzah A FA; Frontini, Mattia M; Chuah, Hun H; Liang, James J; Kavanagh, Simon E SE; Howman, Rebecca R; Ouwehand, Willem H WH; Fuller, Kathryn A KA; Erber, Wendy N WN
Publication Date: 2017-07

Variant appearance in text: RB1: Ser179Thr
PubMed Link: 28502479
Variant Present in the following documents:
  • Main text
View BVdb publication page